Number of the records: 1
lymfocyty infiltrujúce nádor
SYS d016246 LBL 00000cz--a2200000n--4500 005 20250606214815.9 008 920606|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a A11.118.637.555.567.650 065 $a A15.145.229.637.555.567.650 065 $a A15.382.490.555.567.650 066 $a 01 $c 03 150 $a lymfocyty infiltrujúce nádor $x CH $x CL $x CY $x DE $x EN $x IM $x ME $x MI $x PA $x PH $x PS $x RE $x TR $x UL $x VI $2 slo 450 $w v $a Tumor-Derived Activated Cell $2 eng 450 $w v $a Tumor-Derived Activated Cells $2 eng 450 $w v $a Tumor Infiltrating Lymphocyte $2 eng 450 $w v $a Tumor-Infiltrating Lymphocyte $2 eng 450 $w v $a Tumor-Infiltrating Lymphocytes $2 eng 450 $w v $a lymfocyt infiltrujúci nádor $2 slo 450 $w v $a tumor infiltrujúce lymfocyty $2 slo 450 $w v $a nádor-infiltrujúce leukocyty $2 slo 450 $w v $a bunky pochádzajúce z nádoru, aktivované $2 slo 450 $w v $a bunky odvodené od nádoru, aktivované $2 slo 550 $7 sllk_us_auth*d016219 $Y Immunotherapy, Adoptive $w p $a imunoterapia adoptívna 665 $a 91 $2 eng 665 $a Lymphocytes (1976-1990) $2 eng 665 $a T-Lymphocytes (1977-1990) $2 eng 665 $a T-Lymphocytes, Cytotoxic (1984-1990) $2 eng 680 9-
$i Lymphocytes that show specificity for autologous tumor cells. Ex vivo isolation and culturing of TIL with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer. $2 eng 680 $a subpopulations: coordinate with LYMPHOCYTE SUBSETS or specifics $2 eng 750 -2
$a Lymphocytes, Tumor-Infiltrating $2 eng 980 $x M
Number of the records: 1